Cargando…

A Science-Based Methodology Framework for the Assessment of Combination Safety Risks in Clinical Trials

Multiple components factor into the assessment of combination safety risks when two or more novel individual products are used in combination in clinical trials. These include, but are not limited to, biology, biochemistry, pharmacology, class effects, and preclinical and clinical findings (such as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patera, Andriani C., Maidment, Julie, Maroj, Brijesh, Mohamed, Ahmed, Twomey, Ken
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Current Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205853/ https://www.ncbi.nlm.nih.gov/pubmed/37099245 http://dx.doi.org/10.1007/s40290-023-00465-z

Ejemplares similares

A Structured Methodology to Assess Safety Signal Strength and Inform Causality Assessment
por: Sullivan, Tim, et al.
Publicado: (2022)

Methodological Considerations for Studies in Sport and Exercise Science with Women as Participants: A Working Guide for Standards of Practice for Research on Women
por: Elliott-Sale, Kirsty J., et al.
Publicado: (2021)

Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures
por: Prati, Francesco, et al.
Publicado: (2012)

Expert recommendations on the assessment of wall shear stress in human coronary arteries: existing methodologies, technical considerations, and clinical applications
por: Gijsen, Frank, et al.
Publicado: (2019)

Assessing the Safety of COVID-19 Vaccines: A Primer
por: Petousis-Harris, Helen
Publicado: (2020)

A Principles Framework for Digital Provision of Medical Information for Healthcare Professionals
por: Mohamed, Susan, et al.
Publicado: (2023)

Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation
por: Paquette, Miney, et al.
Publicado: (2020)

Specialist Coaching Integrated into a Department of Methodology in Team Sports Organisations
por: Otte, Fabian W., et al.
Publicado: (2020)

Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible?
por: Jit, Mark, et al.
Publicado: (2016)

Practical Blood Flow Restriction Training: New Methodological Directions for Practice and Research
por: Aniceto, Rodrigo Ramalho, et al.
Publicado: (2022)

Financing Drug Innovation in the US: Current Framework and Emerging Challenges
por: Cutler, David, et al.
Publicado: (2020)

Computational Approaches for Pharmacovigilance Signal Detection: Toward Integrated and Semantically-Enriched Frameworks
por: Koutkias, Vassilis G., et al.
Publicado: (2015)

A New Framework for Co-Creating Telehealth for Cancer Care with the Patient Community
por: Addario, Bonnie, et al.
Publicado: (2023)

Combining Isotopic Tracer Techniques to Increase Efficiency of Clinical Pharmacokinetic Trials in Oncology
por: Roosendaal, Jeroen, et al.
Publicado: (2020)

Fuel for the Work Required: A Theoretical Framework for Carbohydrate Periodization and the Glycogen Threshold Hypothesis
por: Impey, Samuel G., et al.
Publicado: (2018)

Advancing the Field of Pharmaceutical Risk Minimization Through Application of Implementation Science Best Practices
por: Smith, Meredith Y., et al.
Publicado: (2014)

Future Evolution of Biosimilar Development by Application of Current Science and Available Evidence: The Developer’s Perspective
por: Cohen, Hillel P., et al.
Publicado: (2023)

Artificial Intelligence and the Future of the Drug Safety Professional
por: Danysz, Karolina, et al.
Publicado: (2018)

‘Knowing as we go’: a Hunter-Gatherer Behavioural Model to Guide Innovation in Sport Science
por: Woods, Carl T., et al.
Publicado: (2020)

Weaving Lines of Inquiry: Promoting Transdisciplinarity as a Distinctive Way of Undertaking Sport Science Research
por: Woods, Carl T., et al.
Publicado: (2021)

Mental Health In Elite Athletes: Increased Awareness Requires An Early Intervention Framework to Respond to Athlete Needs
por: Purcell, Rosemary, et al.
Publicado: (2019)

Cardiovascular Safety Profile of Dapoxetine during the Premarketing Evaluation
por: Kowey, Peter R., et al.
Publicado: (2012)

Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many
por: Cadogan, Cathal A., et al.
Publicado: (2015)

Black Swan Events and Intelligent Automation for Routine Safety Surveillance
por: Kjoersvik, Oeystein, et al.
Publicado: (2022)

Measurement of Energy Intake Using the Principle of Energy Balance Overcomes a Critical Limitation in the Assessment of Energy Availability
por: Tarnowski, Caroline A., et al.
Publicado: (2023)

Development of New Formulations of Biologics: Expectations, Immunogenicity, and Safety for Subcutaneous Trastuzumab
por: Pimentel, Franklin Fernandes, et al.
Publicado: (2018)

Safety of Janus Kinase Inhibitors in Older Patients: A Focus on the Thromboembolic Risk
por: Rajasimhan, Suraj, et al.
Publicado: (2020)

Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties
por: Smit, Cornelis, et al.
Publicado: (2020)

The Patient’s Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization
por: Smith, Meredith Y., et al.
Publicado: (2016)

Pushing boundaries of video review in trauma: using comprehensive data to improve the safety of trauma care
por: Nolan, Brodie, et al.
Publicado: (2020)

Safety of International Professional Sports Competitions During the COVID-19 Pandemic: The Association Football Experience
por: Caniza, Horacio, et al.
Publicado: (2022)

Dispositions and Causality Assessment in Pharmacovigilance: Proposing the Dx3 Approach for Assessing Causality with Small Data Sets
por: Anjum, Rani Lill, et al.
Publicado: (2022)

Intersectionality and reflexivity—decolonizing methodologies for the data science process
por: Boyd, A.E.
Publicado: (2021)

Determining Value in Health Technology Assessment: Stay the Course or Tack Away?
por: Caro, J. Jaime, et al.
Publicado: (2018)

Assessments of the Value of New Interventions Should Include Health Equity Impact
por: Jansen, Jeroen P., et al.
Publicado: (2022)

Regulatory and Health Technology Assessment Considerations for Disease-Modifying Drugs in Alzheimer’s Disease
por: Bouvy, Jacoline C., et al.
Publicado: (2018)

Using Discrete Choice Experiments to Inform the Benefit-Risk Assessment of Medicines: Are We Ready Yet?
por: Vass, Caroline M., et al.
Publicado: (2017)

Early Benefit Assessments in Oncology in Germany: How Can a Clinically Relevant Endpoint Not Be Relevant to Patients?
por: Ruof, Jörg, et al.
Publicado: (2015)

Different Weights of the Evidence-Based Medicine Triad in Regulatory, Health Technology Assessment, and Clinical Decision Making
por: Schlegl, Evelyn, et al.
Publicado: (2017)

Enhancing the value of accelerometer-assessed physical activity: meaningful visual comparisons of data-driven translational accelerometer metrics
por: Rowlands, Alex V., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fahnuippj12ggcu1tm9onpc4dc